8501 ORAL Phase ll-trial of Concomitant Hyperfractionated-accelerated Radiotherapy (HART) With Cisplatin (Cis) Plus Cetuximab (Cet) for Locoregionally Advanced Inoperable Squamous Cell Head and Neck Cancer – Early Response and Acute ToxicitiesThomas Kuhnt, Juergen Dunst, A. Pirnasch et al.|European Journal of Cancer|2011Cited by 0